bioAffinity Technologies, Inc. (BIAF)
2.15
+0.22
(+11.40%)
USD |
NASDAQ |
Nov 18, 16:00
2.08
-0.07
(-3.26%)
After-Hours: 20:00
bioAffinity Technologies Shareholders Equity (Quarterly) : 3.915M for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 3.915M |
| June 30, 2026 | 3.769M |
| March 31, 2026 | 3.661M |
| December 31, 2025 | 7.278M |
| September 30, 2025 | 8.902M |
| June 30, 2025 | -2.136M |
| March 31, 2025 | 1.439M |
| December 31, 2024 | 2.602M |
| September 30, 2024 | 3.121M |
| June 30, 2024 | 3.433M |
| March 31, 2024 | 5.257M |
| December 31, 2023 | 4.855M |
| Date | Value |
|---|---|
| September 30, 2023 | 6.994M |
| June 30, 2023 | 8.098M |
| March 31, 2023 | 9.668M |
| December 31, 2022 | 11.04M |
| September 30, 2022 | 12.60M |
| June 30, 2022 | -12.74M |
| March 31, 2022 | -12.68M |
| December 31, 2021 | -11.75M |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | -11.03M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | 137.58M |
| Perspective Therapeutics, Inc. | 294.68M |
| MiMedx Group, Inc. | 211.08M |
| Veracyte, Inc. | 1.433B |
| T2 Biosystems, Inc. | -- |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 7.554M |
| Total Liabilities (Quarterly) | 3.639M |
| Debt to Equity Ratio | 0.3827 |
| Current Ratio | 1.511 |
| Net Debt Paydown Yield | -2.16% |